In the fetal mouse testis, PIWI-interacting RNAs (piRNAs) guide PIWI proteins to silence transposons but, after birth, most post-pubertal pachytene piRNAs map to the genome uniquely and are thought to regulate genes required for male fertility. In the human male, the developmental classes, precise genomic origins and transcriptional regulation of postnatal piRNAs remain undefined. Here, we demarcate the genes and transcripts that produce postnatal piRNAs in human juvenile and adult testes. As in the mouse, human A-MYB drives transcription of both pachytene piRNA precursor transcripts and messenger RNAs encoding piRNA biogenesis factors. Although human piRNA genes are syntenic to those in other placental mammals, their sequences are poorly conserved. In fact, pachytene piRNA loci are rapidly diverging even among modern humans. Our findings suggest that, during mammalian evolution, pachytene piRNA genes are under few selective constraints. We speculate that pachytene piRNA diversity may provide a hitherto unrecognized driver of reproductive isolation.
I n animal germ cells, PIWI-interacting RNAs (piRNAs) guide PIWI proteins to silence transposons, maintain genome integrity and promote fertility. Unlike microRNAs or small interfering RNAs, piRNAs are processed from long, single-stranded precursor transcripts and have 2′-O-methyl-modified 3′ termini [1] [2] [3] [4] [5] . Transposon and viral silencing is probably the ancestral role of piR-NAs [6] [7] [8] [9] and, in the mouse fetal testis, piRNAs silence active transposons 10, 11 . Unlike other animals, placental mammals also produce abundant piRNAs from transposon-depleted, unique non-coding sequences transcribed by RNA polymerase II (RNAP II) 1, 2, [12] [13] [14] [15] [16] [17] . In mice, mutations in the proteins required to make these 'pachytene' piRNAs lead to male sterility but loss of piRNAs from individual loci rarely has a consequence 15, 18, 19 .
Immediately after birth, mouse germ cells produce 26-27-ntlong, MILI-bound, pre-pachytene piRNAs derived from the coding sequences or 3′ untranslated regions (3′ UTRs) of messenger RNAs 1, [10] [11] [12] 14, 20 . At the onset of the pachytene stage of meiosis, the transcription factor A-MYB induces pachytene piRNA precursor transcription and pachytene piRNAs largely replace pre-pachytene piRNAs, accounting for ~95% of all piRNAs in the adult mouse testis 14 . A-MYB drives the coordinated transcription of ~100 pachytene piRNA genes, as well as genes encoding proteins required for pachytene piRNA production, cell cycle progression and meiosis 14, 21 . Genes activated by A-MYB include A-Myb itself and Miwi, which binds 30-nt pachytene piRNAs 2, 14, 20 . A-MYB also maintains MILI expression in pachytene spermatocytes: ~84% of pachytene piRNAs are bound to MIWI and ~16% to MILI 14, 20 .
Human piRNA-producing loci have been roughly mapped using piRNA sequences 1, 2, 22, 23 but the classes, precise genomic locations and transcription factors regulating human piRNA loci remain unknown. Here, we use 5′ methyl-guanosine cap sequencing (Cap-seq), poly(A) site-sequencing (PAS-seq) and chromatin immunoprecipitation (ChIP) of histone H3 trimethylated on lysine 4 (H3K4me3) to define the juvenile and adult piRNA-producing genes and transcripts in human testis. As in mouse, human pre-pachytene piRNAs mainly derive from mRNA coding sequences or 3′ UTRs whereas pachytene piRNAs derive from long, non-coding RNAs (lncRNAs) often divergently transcribed from a central promoter. Interestingly, ChIP data suggest that A-MYB coordinates the transcription of ~55% of human pachytene and macaque piRNA-producing genes. A-MYB also binds the promoters of ~74% of genes encoding piRNA biogenesis proteins in macaques, but only ~30% in humans. One-third of human pachytene piRNA-producing genes can be found at the syntenic location in the genomes of other Eutherian mammals: half are restricted to primates while ~18% are humanspecific. While pachytene piRNA gene promoters are well conserved, piRNA sequences themselves have diverged rapidly among placental mammals. Moreover, the sequences of pachytene piRNAs vary within the human population more than any other genomic feature. We speculate that pachytene piRNA diversity may provide a hitherto unrecognized driver of Eutherian reproductive isolation.
Results
Three classes of piRNA-producing loci in postnatal human testis. To begin to classify the piRNAs produced during human spermatogenesis, we used strand-specific RNA sequencing to assemble the RNA transcripts and small (25-31 nt) RNA sequencing to define the piRNA repertoire of the postnatal human testis (Supplementary Table 1 ). De novo assembly identified 306,503 mRNA and lncRNA transcripts mapping to 125,526 discrete genomic loci (Extended Data Fig. 1a ). Mapping the piRNA sequences from one juvenile and seven adult testes to the testis transcriptome identified 9,891 piRNA-producing transcripts corresponding to 724 genomic loci. Comparing the juvenile and adult abundance of piRNAs from each of these loci revealed three distinct classes of temporal expression (Extended Data Fig. 1b ): (1) 618 loci (9,065 transcripts) whose piRNAs changed <twofold between juvenile and adult samples, consistent with little or no change in piRNA concentration 14 ; (2) ten loci (147 transcripts) whose piRNA abundance increased ≥2-fold but <4-fold in adult testis; and (3) 96 loci (679 transcripts) whose piRNA abundance in adult was ≥4-fold higher than in juvenile. These three classes of human piRNA-producing loci are analogous to the three well-defined piRNA types in the mouse postnatal testis: pre-pachytene, hybrid and pachytene 14 .
To polish our annotations, we manually curated the annotations for the 100 most abundant pre-pachytene loci and all 10 hybrid and 96 pachytene loci. We removed 17 pre-pachytene and 7 pachytene loci that overlapped with small nucleolar RNAs or had unusually long transcripts probably generated by transcript assembly errors. The resulting 182 loci-83 pre-pachytene, 10 hybrid and 89 pachytene-together account for ~92% of piRNAs in the adult human testis ( Fig. 1a ). Supporting our classification of piRNAs that increase <twofold from juvenile to adult, re-analysis of published RNA sequencing data for purified germ cell subtypes 24 showed that the steady-state abundance of precursor transcripts for these 83 prepachytene, piRNA-producing loci remained constant from quiescent spermatogonia to late pachytene spermatocytes. In contrast, transcript abundance for the 89 pachytene piRNA loci increased ~4-fold from quiescent spermatogonia (median = 5.9 reads per million unique mapped reads per thousand nucleotides (RPKM)) to pachytene spermatocytes (median = 22.7 RPKM).
To further test our set of 182 annotated piRNA-producing genes, we obtained and analysed an additional two juvenile and seven adult human testes. Analysis of the abundance of piRNAs in these samples using our annotated 182 loci recapitulated the differential expression of pre-pachytene, hybrid and pachytene piRNA genes between juvenile and adult ( Fig. 1b and Extended Data Fig. 1c ). As in mice, all human pachytene piRNA genes reside on autosomal chromosomes, probably because most genes on the sex chromosomes are silenced during meiosis 25 (Extended Data Fig. 1d and Supplementary Table 2 ).
Of the 83 pre-pachytene piRNA loci, 75 correspond to proteincoding genes (Extended Data Fig. 2a ). Pre-pachytene piRNAs dominate the juvenile testis piRNA pool, comprising 93% of all piRNAs (median = 630 reads per million (RPM)) but only 9.5% of piRNAs in adult testis (median = 333 RPM). Conversely, pachytene piRNAs dominate adult piRNA production, accounting for ~90% of all piRNAs in adult human testis. The median abundance of piR-NAs mapping to the 89 pachytene piRNA genes was 82-fold greater in adult (931 RPM) than in juvenile testis (11 RPM) . Most pachytene piRNA genes (75 of 89) reside in genomic regions that do not encode proteins, and 35 of 89 loci are divergently transcribed from a bidirectional central promoter (Extended Data Fig. 2b ). None of the 83 annotated pre-pachytene piRNA genes shows evidence of bidirectional transcription. We conclude that, like mice, humans produce piRNAs from discrete loci that are transcribed, spliced and processed into pachytene piRNAs when primary spermatocytes enter the pachytene stage of meiosis.
Human piRNA-producing loci are transcribed by RNAP II. We performed chromatin immunoprecipitation sequencing (ChIP-seq) of histone H3 trimethylated at H3K4me3, Cap-seq and PAS-seq to curate the location of transcription start sites (TSSs) and transcript 3′ ends for the 182 piRNA-producing loci (Extended Data Fig. 3a ). As in mice, canonical RNAP II transcription generates human piRNA precursors: in human postnatal testis, pre-pachytene, hybrid and pachytene piRNA precursor transcripts contained 5′ caps and 3′ poly(A) tails (Extended Data Fig. 3a,b ). Moreover, human piRNAs derive from spliced transcripts (Extended Data Fig. 3c ): median piRNA density within the exons of pre-pachytene piRNA genes (26 RPKM) was 65-fold higher than in introns (0.4 RPKM), and median piRNA density within the exons of the pachytene piRNA genes (260 RPKM) was 144-fold greater than that of the introns (1.8 RPKM).
The 182 piRNA-producing loci defined here account for >2 million distinct piRNA species in adult testis and ~0.7 million in juvenile. Previous annotations of human piRNA-producing loci relied on piRNA density 2, 22, 23 . Our annotations, based on piRNA abundance and transcript and gene structure, represent fewer genomic base pairs (bp) (2,601,201 bp) but account for ~92% of all uniquely mapped piRNAs with at least two reads in adult testis (Extended Data Fig. 4a ).
Human pachytene piRNA exons are depleted of transposons. One ancestral function of piRNAs is to silence germline transposons 1, 2, [6] [7] [8] [10] [11] [12] [26] [27] [28] . As expected, the transposon content of human pre-pachytene piRNA precursors (median = 7%), which are typically mRNAs, resembled that of other mRNAs (Extended Data Fig.  4b ). Hybrid (median = 20%) and pachytene (median = 28%) piRNA precursors contained more transposon sequence than mRNAs but less than lncRNAs (median = 29%). Notably, the introns of pachytene piRNA precursors, which are removed before piRNAs are generated, have a transposon content (median = 41%) similar to those of mRNAs (median = 43%) and lncRNAs (median = 44%). We observed that long terminal repeat retrotransposons (14.2%) were more prevalent within pachytene piRNA genes than other classes of transposable elements (Extended Data Fig. 4c ). However, LINE elements were particularly depleted from the pre-pachytene piRNA genes, suggesting selection against insertion of LINE elements into coding sequences (Extended Data Fig. 4c ). The depletion of transposon sequences from the exons of pachytene piRNA genes suggests that these piRNAs have functions beyond transposon silencing.
Further supporting this idea, transposons in the exons of human pachytene piRNA genes have greater divergence rates (average divergence rate = 0.193) than those in pre-pachytene piRNA genes (average divergence rate = 0.176) or those across the genome as a whole (average divergence rate = 0.186). Because older transposons undergo greater sequence drift than young, active transposons, we conclude that transposons in the exons of pachytene piRNAproducing loci are, on average, older than those in pre-pachytene piRNAs or the genome as a whole. Older transposons are less likely to be active, consistent with the idea that the primary function of pachytene piRNAs is to regulate gene expression rather than to silence transposons.
A-MYB regulates human pachytene piRNA production. In mice, the transcription factor A-MYB (MYBL1) drives the expression of most pachytene piRNA loci and many mRNAs that encode piRNA biogenesis factors 14, 21 . To test whether A-MYB regulates pachytene piRNA production in humans, we performed A-MYB ChIP-seq from adult human testis ( Fig. 1a) . A-MYB peaks (false discovery rate (FDR) < 0.05) were located within 500 bp of the TSSs of 655 genes ( Supplementary Table 3 ), including 49 pachytene piRNA genes (16 bidirectional, 33 unidirectional, ~55% of all pachytene piRNA genes; Fig. 1a and Extended Data Fig. 2b ). The median distance from pachytene piRNA TSSs to the nearest A-MYB peak was 0 bp (Fig. 1c ). We used ChIP-seq of H3K4me3 to map the promoters of the 182 pre-pachytene, hybrid and pachytene piRNA-producing loci (Extended Data Fig. 3a ). All 49 pachytene piRNA gene promoters bound by A-MYB were enriched for the canonical A-MYBbinding motif, CAGTT, beneath the ChIP-seq peak (expected value by chance, E = 1 × 10 −44 ; Fig. 1d ). Human A-MYB also bound the promoters of genes HIWI, HENMT1, HILI2, DDX39A and FKBP6, all encoding proteins required for piRNA production, as well the A-MYB promoter itself ( Fig. 1d and Supplementary Table 3 ). Unlike in mice, where A-MYB binds the promoters of 99% of pachytene piRNA genes and 95% of known piRNA biogenesis protein genes 14 , the promoters of ~45% of human pachytene piRNA-producing genes and 70% of genes encoding proteins known to participate in piRNA biogenesis were not bound by A-MYB. Accordingly, the promoters of ~45% of human pachytene piRNA genes lack an identifiable A-MYB-binding motif, compared to just 11% in mice. (Similar numbers of piRNA biogenesis genes lack an A-MYBbinding motif in both humans and mice.) Thus, additional transcription factors may be required to coordinate transcription of human pachytene piRNA precursors and biogenesis factors.
To test the idea that additional transcription factors may act with A-MYB to drive pachytene piRNA production, we sequenced piRNAs from purified spermatogonia and primary spermatocytes from mice homozygous for the A-Myb repro9 mutation 21 , in which a point mutation within exon 6 leads to alternative splicing that truncates the A-Myb mRNA (Extended Data Fig. 5a ). For comparison, we sequenced the piRNAs in primary spermatocytes of Miwi −/− mutant mice, which lack the 30-nt pachytene piRNAs normally bound to MIWI but retain the 26-27-nt pachytene piR-NAs associated with MILI 1,10-12 . Overall pachytene piRNA abundance in A-Myb repro9 primary spermatocytes was reduced ~25-fold (median = 112 RPM) compared to wild-type primary spermatocytes (median = 2,801 RPM). Nonetheless, pachytene piRNA abundance was 2.1-fold greater in A-Myb repro9 mutant primary spermatocytes than in mutant spermatogonia (median = 53 RPM), suggesting that even without A-MYB, some pachytene piRNA loci are transcriptionally activated as spermatogonia differentiate into primary spermatocytes (Extended Data Fig. 5b ). The abundance of MIWIbound, 30-nt piRNAs increased just 1.8-fold in A-Myb repro9 primary spermatocytes (median = 16 RPM versus 9 for spermatogonia), whereas the abundance of MILI-bound, 26-27-nt piRNAs increased 2.6-fold in mutant primary spermatocytes (median = 45 RPM versus 17). This probably reflects the 50-fold reduced transcription of Miwi in A-Myb repro9 (ref. 14 ) , making less MIWI available for piRNA loading. We conclude that, in both mice and humans, the regulation of pachytene piRNA transcription involves additional factors beyond A-MYB.
Pachytene piRNA precursor expression defines three groups of adult testis samples. Unsupervised hierarchical clustering of the transcriptomes ( Fig. 2a ) of all 14 adult samples revealed three groups with distinct patterns of pachytene piRNA abundance ( Fig. 2b ) or modal piRNA length (Extended Data Fig. 6a ). Group 1 testes had the most pachytene piRNAs (median = 1,924 RPM) compared to group 2 (median = 971 RPM) or group 3 (median = 395 RPM). Median piRNA abundance in the juvenile samples was 14 RPM. While 30-nt piRNAs predominated in group 1 (median of average piRNA length = 28.2 nt), group 2 testes contained fewer 30-nt and more 26-nt piRNAs (median of average piRNA length = 27.5 nt). Group 3 testes contained few 30-nt piRNAs (median of average piRNA length = 27.2 nt), even though they were from post-pubertal men (Extended Data Fig. 6a ). Group 3 had ~2.1-fold more 26-27-nt pre-pachytene piRNAs and ~4.5-fold fewer 30-nt pachytene piR-NAs than group 1, while group 2 had twice as many 26-27-nt prepachytene piRNAs and half as many pachytene piRNAs as group 1 (Fig. 3a ). For all three groups of adult testes, piRNA precursor transcript abundance mirrored piRNA levels ( Fig. 2c ), suggesting that group 2 and group 3 testes make fewer pachytene piRNAs, at least partly because they transcribe fewer pachytene piRNA precursors. Impaired A-MYB expression in group 3 testis. Our data suggest that A-MYB drives transcription of pachytene piRNA genes, HIWI and other piRNA biogenesis genes in human testis ( Fig. 1a,c,d ). In addition to reduced piRNA precursor transcript abundance, group 2 and 3 testes showed reduced expression of 140 genes regulated by A-MYB, including three encoding piRNA biogenesis proteins ( Fig. 3b and Supplementary Table 3 ), suggesting that A-MYB function might be compromised in these testes. Indeed, compared to group 1, A-MYB mRNA levels were reduced ~1.7-and ~4.8-fold in groups 2 and 3, respectively. Consistent with the reduced levels of 30-nt pachytene piRNAs, HIWI mRNA levels were similarly reduced compared to group 1: ~1.7-and ~6.2-fold lower in groups 2 and 3, respectively ( Fig. 3c ). HILI mRNA abundance in group 3 was half that of group 1. In mice, A-MYB increases transcription of Mili 14 . Both A-MYB and HIWI protein levels were reduced in group 2 and barely detectable in group 3 testes ( Fig. 3d and Extended Data Fig. 6b ,c). In addition to reduced steady-state transcript abundance for genes producing pachytene piRNAs and those encoding piRNA pathway proteins, group 3 testes had a ~2.3-fold lower median mRNA abundance for 1,416 reproduction-related genes (median abundance = 2.5 RPKM) compared to group 1 (median abundance = 4.4 RPKM; Fig. 3b ). In contrast, median mRNA abundance for 3,237 immunity-related genes was comparable among all three groups (Fig. 3b ). Group 3 testes appear to be azoospermic-the cause of this azoospermia is not known; RNA sequencing detected non-synonymous mutations in neither the A-MYB nor HIWI coding sequence in the samples. Because information about the health of the testis donors is unavailable, we cannot exclude that the individuals were exposed to mutagens or chemotherapy toxic to the male gonad 29 .
Pachytene piRNA expression accompanies the progression of human spermatogenesis. The three groups of testes afforded an opportunity to examine the developmental timing of pachytene piRNA expression in human spermatogenesis (Extended Data Fig. 7a ). All germ cell types were present in group 1 testes, whereas group 2 testes had disorganized seminiferous tubules and contained fewer primary spermatocytes as well as fewer round and elongating spermatids. Group 2 testes were arrested early in spermatogenesisthe most abundant group 3 germ cells were spermatogonia adjacent to the basal lamina.
The transcript levels of 5,988 genes decreased and 2,172 increased in group 3 testes compared to group 1 (>2-fold change and FDR < 0.001; Extended Data Fig. 7b ). Among RNAs with decreased abundance in group 3, 44% (2,605) corresponded to protein-coding genes and these were enriched for genes involved in male reproduction (597), including 81 genes related to meiosis and 111 related to cilium organization, assembly and movement (Extended Data Fig. 7c ). Among mRNAs with significantly increased abundance in group 3 testes, 22 genes were related to transposition (n = 8) or viral defence (n = 14), suggesting that group 3 comprised unhealthy testis samples. Therefore, we reanalysed the change in expression of the 182 annotated piRNA-producing genes between juvenile and adult samples using only groups 1 and 2. Analysis of the abundance of piRNAs using our annotated 182 genomic loci recapitulated the differential expression of pre-pachytene, hybrid and pachytene piRNA genes between juvenile and healthy adult samples (Extended Data Fig. 8a,b ). We conclude that, as in mice, pachytene piRNA expression accompanies the progression of spermatogenesis through meiosis in the human testis.
In mice, A-Myb and Miwi mRNAs and pachytene piRNAs appear at the onset of pachytene spermatocyte development 14, 21, 30 . Similarly, human group 1 testes showed strong nuclear localization of A-MYB in pachytene spermatocytes and cytoplasmic localization of HIWI in pachytene and round spermatids (Extended Data Fig.  7a ), suggesting that the feedforward regulation of piRNA production orchestrated by A-MYB is evolutionarily conserved. A-MYB and HIWI proteins were below the limit of detection for immunohistochemistry in group 2 and group 3 testes.
Feedforward regulation of piRNA production by A-MYB is conserved in macaque.
The transcription factor A-MYB is conserved across vertebrates 31, 32 . A-MYB ChIP-seq of Macaca mulatta (rhesus macaque) testis identified 18,579 genomic regions with significant A-MYB peaks (FDR < 0.05). These include 7,209 protein-coding genes with A-MYB peaks within 500 bp upstream of their annotated TSSs (Supplementary Table 3 ). As in both humans and mice, the promoters of macaque A-MYB, PIWIL1 and other piRNA biogenesis genes were bound by A-MYB ( Fig. 4a and Supplementary  Table 3 ). For the 12 M. mulatta genes known to function in piRNA production and also bearing an A-MYB peak, the median distance between the TSS and the nearest A-MYB peak was 0 bp (Fig. 4b ).
We used piRNA density to define 189 piRNA-producing loci in M. mulatta (Supplementary Table 4 ): A-MYB was bound to ~55% (33 protein-coding and 71 non-coding) of piRNAproducing loci ( Fig. 4c and Supplementary Table 3 ). Among those piRNA-producing loci bound by A-MYB, the median distance between the TSS and the nearest A-MYB peak was 0 bp (Fig. 4b) . Figure 4d shows an example of A-MYB occupancy on the promoter of a bidirectionally transcribed, non-coding, M. mulatta piRNA cluster that is syntenic to piRNA clusters in both humans and mice. A6   J1  J2  J3  A11  A13  A14  A12  A7  A8  A9  A10  A1  A3  A2  A4 A5 A6 Human pachytene piRNA genes evolve rapidly despite conservation of their promoters. To investigate how human piRNA genes have diverged from piRNA-producing loci in other mammals, we used piRNA density to define the piRNA-producing loci in marmoset (Callithrix jacchus) and rat (Rattus norvegicus), both placental mammals; platypus (Ornithorhynchus anatinus), a monotreme; and grey short-tailed opossum (Monodelphis domestica), a marsupial. Our analyses identified 172 piRNA-producing loci in marmoset, 124 in rat, 95 in platypus and 207 in opossum (Supplementary Table 4 ). Many of these piRNA-producing genes appear to be non-coding: 69% (130) in macaque, 77% (133) in marmoset, 92% (114) in rat, 95% (89) in platypus and 94% (194) in opossum.
Postnatal piRNA sequences are highly diverse 1, 2, 14 , suggesting that they evolve rapidly. We compared conservation among 46 placental mammals of 5′ UTRs, coding sequences, 3′ UTRs and introns of protein-coding genes; the exons and introns of lncRNA genes; the exons and introns of piRNA-producing genes; and randomly selected, non-transcribed sequences that do not produce piRNAs ( Fig. 5a and Extended Data Fig. 9a ). As expected, protein-coding sequences not making piRNAs were the most conserved transcribed feature (median phastCons score = 0.74) among 46 Eutheria ( Fig. 5a and Extended Data Fig. 9b ). Given that most human and mouse prepachytene piRNAs derive from protein-coding genes, the coding sequence of pre-pachytene genes (median phastCons score = 0.81) was conserved at a similar rate as that of other protein-coding genes, suggesting that mRNAs are exposed to similar selective pressures regardless of whether they produce piRNAs ( Fig. 5a and Extended Data Fig. 9b ). The promoters of human pachytene piRNA genes are far more conserved than their transcribed sequences (Fig. 5a, right) . In fact, pachytene piRNA precursor transcripts appear to be among the least well-conserved transcribed genomic feature we examined, including the exons of lncRNAs and randomly selected non-transcribed sequences ( Fig. 5a and Extended Data Fig. 9b ). Across placental mammals, the lack of DNA sequence conservation of nucleotides making pachytene piRNAs reflects the immense diversity of pachytene piRNA sequences.
Most pre-pachytene piRNA genes started producing piRNAs after the divergence of marsupials and placental mammals. The sequences of the 83 human pre-pachytene piRNA loci are often found at syntenic sites in other placental mammals: of the 74 that reside in regions of synteny in at least one other mammal, 55 are present at the syntenic location not only in placental mammals, but also in opossum, platypus and rooster. Nonetheless, none of these 55 protein-coding genes produces piRNAs in non-placental mammals or birds, suggesting that the ability to produce piRNAs from these mRNAs was acquired after the divergence of placental and non-placental mammals ~160 million years ago 33 . In fact, just nine of the 83 human pre-pachytene piRNA-producing genes produce piR-NAs at the syntenic location in placental mammals other than primates. Another ten human pre-pachytene piRNA-producing genes generate piRNAs at the syntenic location only in primates ( Fig. 5b and Supplementary Table 5 ). We currently cannot explain why some mRNAs produce piRNAs in humans but not in other Eutheria. We note that differences in mRNA abundance are unlikely to explain this phenomenon-mRNAs of comparable abundance often produce piRNAs in humans but not in other species (Extended Data Fig. 10a ). Extended Data Fig. 10b provides examples of genes producing pre-pachytene piRNAs in humans, indicating the evolutionary depth of synteny and piRNA abundance in other species.
Many human pachytene piRNA genes arose after primates diverged from other placental mammals. Among the 89 human pachytene piRNA-producing genes, 29 produce piRNAs from the syntenic location in both primates and at least one additional placental mammal (Fig. 5b,c and Supplementary Table 5 ), suggesting that these 29 human piRNA-producing genes antedate the divergence of primates from other placental mammals ~90 million years ago. Another 44 loci produce piRNAs from the syntenic location only in other primates. The remaining 16 pachytene piRNA loci produce piRNAs only in humans. The absence of these loci in macaque and marmoset implies that the loci are no older than ~30 million years. Notably, more deeply conserved human pachytene piRNA loci produce more piRNAs than younger loci-the abundance of pachytene piRNAs from human loci conserved in at least one other placental mammal (median = 5,188 RPM) was twice that of piRNAs from loci conserved only in primates (median = 2,184 RPM) and 11-fold higher than loci unique to humans (median = 460 RPM) (Extended Data Fig. 10c ).
Pachytene piRNA genes are highly variable among humans. Among 2,504 human genomes sequenced by the 1000 Genomes Project 34 , the mean derived-allele frequency (DAF)-a measure of sequence divergence among individuals within a species-for human pachytene piRNA precursor exons was higher than that of any other transcribed feature we examined and was comparable to that of randomly selected, non-transcribed sequences (Fig. 6a ). To further test the results of the DAF analysis, we measured the nucleotide diversity (π value) at each nucleotide position of human piRNA genes and other transcribed features. Consistently, the π value of human pachytene piRNA precursor exons was higher than that of any other transcribed feature (Fig. 6a) . Counterintuitively, loci with synteny among placental mammals are diverging faster than those with synteny among primates only or those unique to humans (Fig. 6a) , a phenomenon typically associated with old transposons and pseudo-genes, not genes under positive selection to retain function. In fact, loci with synteny are diverging faster than even randomly selected, non-transcribed sequences (Fig. 6a) . Moreover, the exons of pachytene piRNA genes-the sources of piRNAs-were more polymorphic than the introns of pachytene piRNA genes, which are removed before piRNA precursors are processed into piRNAs (Fig. 6a,b) . The slower divergence of pachytene piRNA introns probably reflects conservation of splicing signal sequences ( Fig. 6b ), suggesting that intron removal is required for piRNA processing or function 35, 36 .
Discussion
Here, we report the structure of piRNA-producing genes expressed in the postnatal human testis. We use these data to examine the evolutionary conservation of the transcriptional mechanisms that regulate piRNA production, and of the sequences of the piRNAs themselves.
A-MYB regulation is conserved across mammals. In mouse testis, pachytene piRNA genes are transcribed at the onset of the pachynema when the A-Myb gene is activated 14, 21 . Three lines of evidence suggest that A-MYB coordinates the expression and processing of pachytene piRNAs across Eutherian mammals, including humans. First, A-MYB protein is readily detectable in human pachytene spermatocytes but not in spermatogonia. Second, A-MYB is bound to the promoters of many human pachytene piRNA genes, genes encoding piRNA biogenesis proteins and the A-MYB promoter itself. Third, A-MYB binds to the promoters of macaque piRNA-producing genes, genes encoding piRNA biogenesis proteins, and A-MYB. Given that A-MYB regulation of piRNAproducing genes can be detected in rooster testis 14 , control of piRNA production by this transcription factor appears to have emerged at least ~300 million years ago, in the last common ancestor of birds and mammals 33 , long before the emergence of pachytene piRNAs in Eutheria.
Nevertheless, A-MYB does not account for all pachytene piRNA production. At least half of the promoters of human pachytene piRNA and macaque piRNA-producing genes are not occupied by A-MYB, and some pachytene piRNAs are still made in mouse or human testis with little or no A-MYB. The transcription of pachytene piRNA genes might therefore be sustained by cooperative or compensatory transcription factors that, together with A-MYB, ensure the burst of piRNA production at the pachytene stage of meiosis.
In Drosophilids, germline dual-strand piRNA clusters are transcribed by a non-canonical, heterochromatin-dependent, promoter-independent mechanism that distinguishes the transcription of piRNA precursors from the promoter-dependent, canonical transcription of mRNA 6, [37] [38] [39] [40] . In contrast, Eutherian pachytene piRNA genes appear to be canonical euchromatic transcription units regulated by A-MYB. However, A-MYB also regulates transcription of many genes that are not sources of piRNAs, including those required for meiosis and those that encode piRNA biogenesis factors 14, 21 . How then are pachytene piRNA precursor transcripts distinguished from mRNAs? What marks these genes or their transcripts to produce pachytene piRNAs? If the fate of a piRNA precursor transcript is determined by cis-acting RNA elements, these must be more complex than simply promoter architecture because several mammalian pachytene piRNA genes are transcribed divergently from a central promoter yet produce an mRNA or lncRNA from one arm and a piRNA precursor from the other 14, 41, 42 .
Rapid evolution of pachytene piRNA-producing genes. The genomic locations and promoter sequences of many pachytene piRNA genes are conserved among placental mammals. Nevertheless, the transcribed sequences of the genes have diverged 
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Hs pi6 rapidly, suggesting that they are under little selective pressure. Different pachytene piRNA sequences emerge from syntenic pachytene piRNA genes in different species and presumably regulate different targets. Indeed, a mouse expressing the human pi6 pachytene piRNA gene is male-sterile because it inappropriately silences an mRNA essential for spermatogenesis 13 . We envision that rapid divergence of piRNA sequences may lead to acquisition of distinct sets of targets during mammalian evolution.
Pachytene piRNAs are among the most variable sequences in the human population. Our finding that modern human pachytene piRNA loci with deeper evolutionary conservation are diverging more rapidly than younger loci implies that increased sequence variation plays an intrinsic role in piRNA function. We speculate that the sequences recognized by piRNAs in specific mRNAs drift in parallel with the overall drift of pachytene piRNA sequences among individuals. The testis expresses a more complex repertoire of transcripts than other tissues 43 , allowing a large fraction of the human transcriptome to interact with pachytene piRNAs. In theory, such interactions might probe the compatibility of the paternal and maternal genomes. For example, target RNA cleavage directed by piRNAs from the paternal genomic haplotype could decrease the abundance of mRNA sequence variants encoded by the maternal genome. Such piRNA-dependent transcriptional repression may reduce or enhance the fitness of an individual's sperm. We speculate that pachytene piRNA diversity may therefore be a hitherto unrecognized driver of Eutherian reproductive isolation.
Methods
Human tissue samples. De-identified, frozen human testis and other tissue samples included in the study were obtained from the University of Massachusetts Medical School Tissue and Tumor Bank, except for two adult and two juvenile testis tissue samples that were a gift of K. Orwig (University of Pittsburg, USA).
Additionally, one sample of human testis total RNA was from Ambion (Thermo Fisher Scientific, no. AM7972). The maximum delay from excision of human testis specimens to flash freezing was ~2 h. After receiving frozen samples, they were stored at −80 °C. Tissues were handled on dry ice. Seventeen adult and three prepubertal (juvenile) human testis samples were included in the study ( Supplementary Table 1 ).
Mice. All mice were maintained and used according to the guidelines of the Institutional Animal Care and Use Committee of the University of Massachusetts Medical School. C57BL/6J mice (RRID: IMSR_JAX:000664) were used as wild-type controls. A-Myb mutant mice (B6(C3)-A-Myb repro9/JEbfJ , IMSR no. JAX:027889; ref. 21 ) and Miwi (B6;129-Miwi tm1Hfl/Mmmh , RRID:MMRRC_029995-MU; ref. 30 ) mutant mice were genotyped as previously described 20 .
To characterize the repro9 mutation 21 residing within exon 6 of A-Myb, we isolated total RNA from wild-type adult and 17-days post-partum (dpp) testes and 14.5-dpp heterozygous and homozygous A-Myb repro9 mutant testes. After oligo(dT) primed complementary DNA synthesis, the region spanning the repro9 mutation was amplified by PCR. Sanger sequencing of the amplicon revealed that the C-to-A Mybl1 repro9 mutation creates a strong splice donor at the 5′ end of exon 6, leading to an out-of-frame deletion in the mRNA (Extended Data Fig. 5a ).
Isolation of mouse germ cells by fluorescent activated cell sorting.
Germ cell sorting was performed as previously described 20 . In brief, isolated testes were decapsulated and incubated in 1× Gey's Balanced Salt Solution (GBSS; Sigma, no. G9779), containing 0.4 mg ml -1 of collagenase type 4 (Worthington, no. LS004188), for 15 min at 33 °C, rotating at 150 r.p.m. The seminiferous tubules were washed twice with 1 × GBSS and incubated with 1 × GBSS containing 0.5 mg ml -1 of trypsin and 1 µg ml -1 of DNase I for 15 min at 33 °C, rotating at 150 r.p.m. After trypsin and DNase treatment, tubules were homogenized on ice by gentle, repeated pipetting through a Pasteur pipette for 3 min. Thereafter, trypsin was inactivated with fetal bovine serum (FBS; 7.5% final concentration, v/v). The cell suspension was passed through a 70-µm pre-wetted cell strainer, and cells collected by centrifugation at 300g and 4 °C for 10 min. The pelleted cells were further resuspended in 1 × GBSS containing 5% (v/v) FBS, 1 µg ml -1 DNase I and 5 μg ml -1 Hoechst 33342 (Thermo Fisher Scientific, no. 62249) and incubated for 45 min at 33 °C, rotating at 150 r.p.m. Thereafter, propidium iodide (0.2 μg ml -1 , final concentration; Thermo Fisher Scientific, no. P3566) was added and cells were passed through a 40-µm pre-wetted cell strainer. Finally, cells were sorted at the University of Massachusetts Medical School FACS Core as previously described 44 . Fig. 6 | Sequence variation for different genomic features within the human population. a, Mean DAF of autosomal single-nucleotide polymorphisms (SNPs) and mean nucleotide diversity (π value) for 2,504 human genomes representing 26 different human populations 34 . Whiskers show 95% confidence generated by random sampling 100 times. DAF from 22,604, 10-kb-long, randomly selected non-transcribed genomic regions served as control. b, Metagene plots representing piRNA abundance, DAF and conservation score for intron-containing pachytene piRNA genes (n = 51).
Testis histology and immunohistochemistry. Paraffin-embedded human testis tissue fixed with 4% (v/v) formaldehyde was obtained from either the University of Massachusetts Medical School Tissue and Tumor Bank or K. Orwig. Embedded tissues were sectioned at 4-μm thickness and stained with haematoxylin and eosin (H&E) by the University of Massachusetts Medical School Morphology Core Facility.
Immunohistochemical staining was performed using standard protocols. Briefly, testis sections were de-paraffinized with xylene, dehydrated with ethanol and heated with 1 mM citrate buffer (pH 6.0) to retrieve antigen. Endogenous peroxidase activity was inactivated with 3% (w/v) hydrogen peroxide for 10 min at room temperature. Tissues were blocked with 5% (v/v) horse serum using the ImmPRESS HRP Anti-Rabbit IgG (Peroxidase) Polymer Detection Kit (Vector labs, no. MP-7401). Sections were then incubated with either rabbit anti-A-MYB (Sigma, no. HPA008791; 1:400 dilution) or rabbit anti-MIWI (Abcam, no. ab12337; 1:400 dilution) antibody overnight at 4 °C. Secondary HRP anti-rabbit antibody (Vector labs, no. MP-7401) was applied for 1 h at room temperature, followed by incubation with substrate/chromogen (Thermo Fisher Scientific, no. TA-125-QHDX). Finally, slides were counterstained with haematoxylin, dehydrated and sealed with a coverslip. H&E and immunohistochemistry images were captured using a Leica DMi8 microscope.
Immunoblotting. Frozen testis tissue was homogenized in RIPA buffer (25 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% (v/v) NP-40, 1% (w/v) sodium deoxycholate and 0.1% (w/v) SDS) containing 1 × E-64 protease inhibitor (Sigma, no. E3132). Lysed tissue was sonicated (Branson Digital Sonifier; 450 Cell Disruptor) to break nuclei, then samples were centrifuged at 20,000g for 30 min at 4 °C. The supernatant was transferred to a new tube, and the protein concentration measured (Pierce BCA Protein Assay Kit; Thermo Fisher Scientific, no. 23225). For each sample, 75 µg of total protein was mixed with 1/3-volume loading dye (106 mM Tris-HCl, pH 6.8, 141 mM Tris base, 2% SDS, 10% glycerol, 0.51 mM EDTA, 0.22 mM SERVA Blue G and 0.175 mM phenol red) containing 0.2 M DTT, and heated at 95 °C for 6 min. After denaturion of proteins, samples were resolved by electrophoresis through a 4-20%-gradient polyacrylamide/SDS gel (Thermo Fisher Scientific, no. XP04205BOX) and electro-transferred to polyvinylidene difluoride membrane (Millipore, no. IPVH00010). The membrane was blocked (Blocking Buffer; Rockland Immunochemicals, no. MB-070) for 1 h at room temperature and incubated with rabbit anti-A-MYB (Sigma, no. HPA008791; 1:700 dilution) or rabbit anti-MIWI (Abcam, no. ab12337; 1:1,000 dilution) antibody overnight at 4 °C. The membrane was washed three times with 1 × PBS-T (0.1% (v/v) Tween-20 in 1 × PBS) for 30 min at room temperature and then incubated with secondary donkey anti-rabbit IRDye 680RD antibody (LI-COR, no. 926-68073; 1:5,000 dilution) for 1.5 h at room temperature. Afterwards, the membrane was washed three times with 1× PBS-T for 30 min at room temperature and signal detected (Odyssey Infrared Imaging System; LI-COR). As a loading control, membrane was incubated with mouse anti-ACTIN (Santa Cruz Biotechnology, no. sc-47778; 1:3,000 dilution) antibody for 2 h at room temperature and then goat anti-mouse IRDye 800RD secondary antibody (LI-COR, no. 926-32210; 1:5,000 dilution) as described.
Small RNA library construction and analysis. Total RNA was extracted from frozen human testis tissue using the mirVana miRNA isolation kit (Thermo Fisher Scientific, no. AM1560). Small RNA library construction was performed as described 45 . In brief, 18-34 nt was isolated by separation of total RNA via denaturing electrophoresis through a 15% polyacrylamide gel. To prevent microRNAs and siRNAs entering the library, small RNAs were oxidized with sodium periodate (NaIO 4 ) before 3′ adaptor ligation. The 3′ adaptor (5′-rApp NNN TGG AAT TCT CGG GTG CCA AGG/ddC/-3′ or 5′-rApp TGG AAT TCT CGG GTG CCA AGG/ddC/-3′; Supplementary Table 1 ) was ligated to the RNA in the presence of 50% (w/v) PEG-8000 (Rigaku, no. 1008063). After 3′ ligation, ligated small RNAs (42-60 nt) were purified by denaturing electrophoresis (15% PAGE). Thereafter, the 5′ adaptor was ligated and libraries were sequenced with 79-nt single-end reads (NextSeq500; Illumina).
The 3′ adaptor sequence was removed from the reads, and those reads with PHRED score <5 were mapped to human genome hg19 using piPipes 46 with bowtie 2.2.5 (ref. 47 ), allowing one mismatch. We quantified the length distribution of small RNA reads by normalizing to genome mapping reads reported as RPM. Juvenile sample J1 was sequenced twice (correlation for technical replicates: Pearson's ρ = 0.99). Supplementary Table 1 reports small RNA sequencing statistics.
Long RNA library construction and analysis. Total RNA was extracted from frozen tissues (mirVana miRNA isolation kit; Thermo Fisher Scientific, no. AM1560). Library construction was performed as described 48 , except that rRNA was removed using a pool of antisense oligonucleotides. Briefly, 186 different antisense DNA oligonucleotides (AS oligos) complementary to rRNA sequences were designed and pooled (0.05 µM each; 49, 50 ). Total RNA (1 µg) was mixed with 1 µl pooled ribosomal RNA AS oligos in the presence of 100 mM Tris-HCl (pH 7.4) and 200 mM NaCl at 95 °C and cooled to 22 °C (−0.1 °C s -1 ), then held at that temperature for 5 min. The DNA:RNA hybrids were incubated with 10 U Thermostable RNase H (Epicentre, no. H39500) in 50 mM Tris-HCl (pH 7.4), 0.1 M NaCl and 20 mM MgCl 2 at 45 °C for 30 min. Next, samples were incubated with 4 U of Turbo DNase (Thermo Fisher Scientific, no. AM2238) at 37 °C for 20 min, then purified with RNA Clean and Concentrator-5 (Zymo Research, no. R1015) to isolate RNA >200 nt. RNA libraries were sequenced as 79-nt paired-end reads (NextSeq500; Illumina).
Ribosomal RNA reads were removed using Bowtie 2.2.5 with default parameters 47 , and the remaining reads mapped to human genome hg19 using STAR 2.3 (ref. 51 ). Duplicate reads were removed using SAMtools 1.8 (ref. 52 ). Finally, mapped reads were assigned to protein-coding genes, lncRNAs or piRNA genes using HTSeq 0.9.1 (ref. 53 ). Transcript abundance was reported as RPKM. Unsupervised hierarchical clustering, based on the abundance of protein-coding and non-coding transcripts, was performed as described 54 . Supplementary Table 1 reports RNA sequencing statistics.
PAS-seq library construction and analysis.
Total RNA was extracted from frozen tissues using the mirVana miRNA isolation kit (Thermo Fisher Scientific, no. AM1560). PAS-seq library construction was performed as described 55 . Briefly, poly(A) + RNA was extracted from total RNA using Dynabeads mRNA purification beads (Ambion, no. 61006), then fragmented to 60-80 nt at 70 °C for 7 min by chemical hydrolysis. Fragmented RNA was reverse transcribed using barcoded oligo(dT) oligonucleotides containing sites for forward and reverse Illumina sequencing primers separated by a hexa-ethyleneglycol (Sp18) linker. The oligonucleotides contained unique molecular identifiers (UMIs), to enable duplicate removal, preceded by 5′p-GG for efficient cDNA circularization. cDNA was further circularized using Circligase ssDNA ligase (Illumina, no. CL4111K) at 60 °C for 4 h. Following cDNA circularization, 14 cycles of PCR amplification were performed using the KAPA HiFi library amplification kit (Kapa Biosystems, no. KK2611) and libraries sequenced as 79-nt single-end reads (NextSeq500; Illumina).
Poly(A) tracts and residual adaptor sequences were trimmed from the 3′ ends of those reads passing quality checks. Reads were mapped to human genome hg19 using Bowtie 2.2.5 (ref. 47 ) with parameters -m -best -p4. Poly(A) sites were determined as described 55 . We filtered out internal priming events caused by genomic poly(A) tracts using a naïve Bayes classifier approach 56 . Supplementary  Table 1 reports poly(A) site-sequencing statistics.
Cap-seq library construction and analysis. Total RNA was extracted from frozen tissues using the mirVana miRNA isolation kit (Thermo Fisher Scientific, no. AM1560). Cap-seq libraries were prepared as described, with slight modifications 57 . Briefly, following rRNA removal, poly(A) + RNA was extracted from total RNA using Dynabeads mRNA purification beads (Ambion, no. 61006). RNA was heated to 68 °C for 5 min, then immediately chilled on ice. To prevent 5′ phosphorylated RNA entering the library, RNA samples were treated with 10 U of Antarctic Phosphatase (NEB, no. M0289) at 37 °C for 1 h. Antarctic Phosphatase was inactivated at 70 °C for 5 min, and then RNA extracted with phenol:chloroform:isoamyl alcohol (25:24:1, pH 6.7). The 5′ cap was removed using 20 U of Tobacco Decapping Enzyme (Enzymax, no. LLC, 87) in the presence of 1 mM MnCl 2 at 37 °C for 2 h, followed by phenol:chloroform:isoamyl alcohol extraction. After 5′ ligation, RNA was reverse transcribed using a primer containing 5′-NNN NNN NN-3′ followed by a 3′ adaptor sequence, then amplified by PCR for two cycles with left (5′-CTA CAC GTT CAG AGT TCT ACA GTC CGA-3′) and right (5′-GCC TTG GCA CCC GAG AAT TCC A-3′) primers using 2× NEBNext Q5 High-Fidelity DNA Polymerase Master Mix (NEB, no. M0541). PCR products (length, 200-400 bp) were purified from a 1% agarose gel run in TAE buffer (QIAquick; QIAGEN, no. 28706). After ten additional PCR cycles, Capseq libraries were sequenced as 79-nt single-end reads (NextSeq500; Illumina). Supplementary Table 1 reports Cap-seq statistics.
Chromatin immunoprecipitation and sequencing. ChIP was performed as described 14 , except using frozen tissue. Briefly, frozen tissue was cut into small pieces on dry ice and transferred to 1.7-ml tubes containing ice-cold PBS. Samples were cross-linked with 2% (w/v) formaldehyde at room temperature for 30 min using tumbling end-over-end. Thereafter, fixed tissues were crushed in ChIP lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCl, pH 8.1) using 40 strokes with a 'B' pestle in a Dounce homogenizer (Kimble-Chase), then sonicated (Ultrasonicator; Covaris, no. E220) to shear the chromatin to 150-200 bp. Lysate was then diluted 1:10 with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl) and immunoprecipitated using 5.5 µg of either anti-A-MYB (Sigma, no. HPA008791) or 4.5 µg anti-H3K4me3 (Abcam, no. ab8580). DNA was extracted from the immunoprecipitate with phenol:chloroform:isoamyl alcohol (25:24:1, pH 8), then libraries were generated as described 48 and sequenced as 79-nt paired-end reads (NextSeq500, Illumina).
Raw reads were mapped to the genome using Bowtie 2.2.5 (ref. 47 ) using the parameter -very-sensitive. Duplicate reads were removed using SAMtools 1.8 (ref. 52 ). We used model-based analysis of ChIP-seq (MACS 1.1.2; ref. 58 ) with parameter -q 0.01 to detect A-MYB peaks that were significantly enriched relative to input (1,296 genomic regions; FDR < 0.05). Supplementary Table 1 reports ChIP-seq statistics.
Human piRNA precursor transcript annotation. After mapping reads to the genome using STAR, we used StringTie 1.3.3 (ref. 59 ) to perform genome-based transcriptome assembly. Gene annotations were from Ensembl 90. One juvenile (two technical replicates) and seven adult testis samples were used individually for transcriptome assembly, and each assembly was then merged into a final transcript assembly using the merge function with parameter -m 100 -F 1 -T 1. We retained those transcripts both present in more than one sample and producing ≥100-RPM piRNAs in more than one sample.
Human piRNA gene nomenclature. As in the mouse 14 , human piRNA-producing genes overlapping ≥50% with annotated protein-coding genes were named pi-(GeneName); non-coding piRNA genes were named according to their genomic location and piRNA abundance: (chromosome)-(chromosome segment)-(piRNA RPM).
piRNA gene annotation in other species. We defined piRNA genes in rhesus, marmoset, rat, opossum and platypus as previously described 6 using small RNA-seq data from testis downloaded from GEO (rhesus, GSE40499; marmoset, GSE52927; rat GSE19054; opossum, GSE40499; platypus, GSE40499). Briefly, we scanned the whole genome using 5-kb sliding windows tiled every 1,000 nt to capture the regions mapped by 24-32-ntlong small RNA at a density of >100 RPM. We then merged 5-kb windows within 20 kb of each other. We defined two types of genomic source of piRNAs: (1) piRNA-producing genomic regions that overlap an annotated protein-coding gene, and (2) piRNA-producing sequences unlikely to encode protein-that is, non-coding RNA-producing genes. Genomic sources of piRNAs overlapping a protein-coding gene were named pi-(GeneName). For piRNA clusters derived from non-coding sequences, clusters were named pi-(suffix), where the suffix indicates the rank order of the genomic coordinates of the piRNA cluster. Synteny analysis. Synteny analysis was performed using liftOver from the UCSC toolkit. Human (hg19) piRNA genes were aligned to rhesus (rheMac8), marmoset (calJac3), mouse (mm10), rat (rn6), opossum (monDom5) and platypus (ornAna1) genomes with the command liftOver -minMatch = 0.1. piRNA-producing genes successfully identified in another genome were considered syntenic. Loci producing piRNAs from a syntenic location in other species were considered evolutionarily conserved.
Calculation of DAF and nucleotide diversity (π value)
. Vcf files of 2,504 human genomes containing the DAF of each single-nucleotide polymorphism were downloaded from the 1000 Genomes Project Consortium 34 . In brief, the 1000 Genomes Project Consortium considers those alleles that are different from the ancestral allele-compared to chimpanzee-as derived alleles. We then took those alleles in non-CpG autosomal-chromosome regions and calculated the frequency of derived alleles in each human genome. Mean nucleotide diversity 60 (π) is defined as 2 × DAF × (1 -DAF).
Statistics. Statistics were calculated using R console (https://www.rstudio.com); graphs were generated using R console and Igor Pro 6.37. For box plots, 95% confidence intervals were calculated using Wilcoxon rank-sum test.
Reporting Summary. Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data availability
Sequencing data are available from the National Center for Biotechnology Information Sequence Read Archive using accession number PRJNA506245 and from the Gene Expression Omnibus using accession number GSE135791. Fig. 1 | Strategy for defining human post-natal piRNA genes. a, Strategy for transcriptome assembly, identification of piRNA precursor transcripts, and annotation of genomic loci. Pink rectangles: input for analyses; gray rectangles: bioinformatic tools. Green hexagons: output from analyses. b,c, Histograms showing the change in the abundance of piRNAs produced from piRNA genes between juvenile and adult samples. The analysis was conducted twice: once with the set of samples used to define the piRNA genes (b) and then with an independent set of samples to validate the annotations (c). d, Genomic positions of 182 human piRNA-producing loci on the 22 autosomal chromosomes. Two pre-pachytene piRNA genes were identified on the X chromosome. Fig. 5 | Characterization of the mouse repro9 mutation within exon 6 of A-Myb. a, The repro9 mutation creates a stronger 5′ splice site within exon 6 of A-Myb, leading to a truncated mRNA. Splice site strength was determined using MaxEntScan 13 . b, Heatmaps of the relative abundance of mouse piRNAs mapping to previously defined piRNA genes 14 . piRNA abundance was normalized to the total number of mapped reads. Spg: spermatogonia; SpI: primary spermatocytes. Corresponding author(s): Zhiping Weng, Phillip D. Zamore Last updated by author(s): Jul 15, 2019 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see Authors & Referees and the Editorial Policy Checklist.
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